Top

Published in:

01-10-2012 | Original Article

Polymorphisms in PDCD1 gene are not associated with aplastic anemia in Chinese Han population

Authors: Z. J. Ming, H. Hui, M. Miao, Y. H. Qiu, X. G. Zhang

Published in: Rheumatology International | Issue 10/2012

Abstract

Programmed cell death 1 (PD-1) has recently been reported to have a genetic association in several autoimmune diseases. The object of this study was to investigate the association of PD-1 polymorphisms with aplastic anemia (AA) in the Chinese Han population. In a case–control association study, three single-nucleotide polymorphisms (SNP), PD-1.3 G/A, PD-1.5 C/T, and PD-1.9 T/C, were genotyped in 166 AA patients and 264 healthy controls using polymerase chain reaction-restriction fragment length polymorphism assay. All genotype distributions in the patients and the controls were in Hardy–Weinberg equilibrium. The associations of genotypes and alleles with AA were analyzed. No differences in genotype and allele frequencies were elucidated for SNPs in intron 4 and exon 5. In conclusion, we show no association of selected SNPs in PDCD1 gene with AA in the Chinese Han population.

Nakao S (1997) Immune mechanism of aplastic anemia. Int J Hematol 66:127–134

Shlapatska LM, Mikhalap SV, Berdova AG, Zelensky OM, Yun TJ, Nichols KE, Clark EA, Sidorenko SP (2001) CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol 166:5480–5487PubMed

Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T (1996) Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocyte. Int Immunol 8:765–772

Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T (2003) Autoantibodies against cardiactroponin I are responsible for dilated cardiomyopathy in PD-1 deficient mice. Nat Med 9:1477–1483PubMedCrossRef

Lazar-Molnar E, Chen B, Kari A (2010) Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. PNAS 107:13402–13407PubMedCrossRef

Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T (2005) Establishment of NOD-pdcd11^−/− mice as an efficient animal model of type 1 diabetes. PNAS 102:11823–11828PubMedCrossRef

Lin SJ, Peacock CD, Bahl K (2007) Welsh RM Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation. J Exp Med 204:2321–2333PubMedCrossRef

Keir ME, Francisco LM, Sharpe AH (2007) PD-1 and its ligands in T-cell immunity. Curr Opin Immuno 19:309–314CrossRef

Magnusson V, Lindqvist AK, Castillejo-lopez C, Kristjansdottir H, Steinsson K, Grondal G (2000) Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. Genomics 70:307–314PubMedCrossRef

10.

Iwamoto T, Ikari K, Inoue E, Toyama Y, Hara M, Yamanaka H, Tomatsu T, Momohara S, Kamatani N (2007) Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population. J Hum Genet 52:557–560PubMedCrossRef

11.

Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST (2003) Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62:492–497PubMedCrossRef

12.

Slot MC, Sokolowska MG, Savelkous KG (2008) Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis. Clin Immunol 128:39–45PubMedCrossRef

13.

Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Maurer M, Wiendl H (2005) PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58:50–57PubMedCrossRef

14.

Newby PR, Roberts-Davies EL, Brand OJ, Heward JM, Franklyn JA, Gough SC, Simmonds MJ (2007) Tag SNP screening of the PDCD1 gene for association with Graves’ disease. Clin Endocrinol 67:125–128CrossRef

15.

Lee SH, Lee YA, Woo DH, Song R, Park EK, Ryu MH, Kim YH, Kim KS, Hong SJ, Yoo MC, Yang HI (2006) Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res Ther 8:R163PubMedCrossRef

16.

Prokunina L, Padyukov L, Bennet A, de Faire U, Wiman B, Prince J, Alfredsson L, Klareskog L, Alarcon-Riquelme M (2004) Association of PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 50:1770–1773PubMedCrossRef

17.

Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wiholm BE, Young NS, Leaverton P, Levy M, Shapiro S (1996) Drugs in the aetiology of agranulocytosis and aplastic anemia. Eur J Haematol 60:23–30

18.

Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F (2004) Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 50:2590–2597PubMedCrossRef

19.

Velazquez-Cruz R, Orozco L, Espinosa-Rosales F, Carreno-Manjarrez R, Solis-Vallejo E (2007) Association of PDCD1 polymorphisms with childhood-onset systemic lupus erthematosus. Eur J Hum Genet 15:336–341PubMedCrossRef

20.

Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM, Alarcon-Riquelme M, Lau YL (2005) A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 52:1058–1062PubMedCrossRef

21.

Prokunina L, Castillejo-lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler DJ, Kristjansdottir H, Grondal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jonssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcon-Segovia D, Steinsson K, Alarcon-Riquelme ME (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erthematosus. Nat Genet 70:666–669CrossRef

22.

Thorburn CM, Prokunina-Olsson L, Sterba KA, Lum RF, Seldin MF, Alarcon-Riquelme ME, Criswell LA (2007) Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 8:279–287PubMedCrossRef

23.

Meng Q, Liu X, Yang P, Hou S, Du L, Zhou H, Kijlstra A (2009) PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome. Mol Vis 15:386–392PubMed

24.

Lin SC, Yen JH, Tsai JJ, Tsai WC, Ou TT, Liu HW, Chen CJ (2004) Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 50:770–775PubMedCrossRef

25.

Sakthivel P, Giscombe R, Ramanujam R, Lefverk AK (2009) Polymorphisms in PDCD1 gene are not associated with Wegener’s granulomatosis. Rheumatol Int 29:1247–1250PubMedCrossRef

26.

Fawwaz S, Nikamo P, Torn C, Landin-Olsson M, Lemmark A, Alarcon-Riquelme M (2007) No evidence of association of the PDCD1 gene with type I diabetes. Diabet Med 24:1473–1477PubMedCrossRef

27.

Ni RH, Ihara K, Miyako K, Kuromaru R, Inuo M, Kohno H, Hara T (2007) PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children. Hum Genet 121:223–232PubMedCrossRef

28.

Liu X, Hu LH, Li YR, Chen FH, Ning Y, Yao QF (2011) Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population. Rheumatol Int 2:209–213CrossRef

Title: Polymorphisms in PDCD1 gene are not associated with aplastic anemia in Chinese Han population
Authors: Z. J. Ming
H. Hui
M. Miao
Y. H. Qiu
X. G. Zhang
Publication date: 01-10-2012
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 10/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-011-2127-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Polymorphisms in PDCD1 gene are not associated with aplastic anemia in Chinese Han population

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2012

Pattern of bone mineral density in idiopathic male osteoporosis

Role of glucosamine in the treatment for osteoarthritis

HLA-B27 subtypes in Turkish patients with ankylosing spondylitis and healthy controls

Anti-inflammatory effects of Clematis chinensis Osbeck extract(AR-6) may be associated with NF-κB, TNF-α, and COX-2 in collagen-induced arthritis in rat

Systemic sclerosis sine scleroderma associated with antiphospholipid syndrome

Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page